KRRO - Korro Bio, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$15.00
DETAILS
HIGH:
$15.00
LOW:
$15.00
MEDIAN:
$15.00
CONSENSUS:
$15.00
UPSIDE:
68.35%
About Korro Bio, Inc. (https://www.korrobio.com)
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Ram Aiyar | Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director | 1978 | $852,656 USD |
| Loic Vincent | Chief Scientific Officer | – | $642,518 USD |
| Jeffrey Cerio | Senior Vice President, General Counsel & Corporate Secretary | – | $587,500 USD |
| Jean-Francois Formela | Co-Founder & Director | 1957 | $51,500 USD |
| Andrew Fraley | Co-Founder & Advisor | – | – |
| Gaozhong Zhu | SVP of Chemistry, Manufacturing and Controls & Technical Operations | – | – |
| Joshua Rosenthal | Co-Founder & Advisor | – | – |
| Oliver Dolan | Senior Vice President of Finance & Principal Accounting Officer | 1983 | – |
| Stephanie Engels | Chief People Officer | – | – |
| Todd Chappell | Chief Operating Officer | 1973 | – |